CX3CL1 and rheumatoid arthritis: Quetmolimab, a humanized anti-CX3CL1 monoclonal antibody, is undergoing clinical trials for the treatment of various inflammatory diseases, including rheumatoid arthritis and Crohn disease [43,44].